Haber, D A <br/><br/>
Molecular targeted therapy of lung cancer: EGFR mutations and response to EGFR inhibitors.  [electronic resource] 

 -  Cold Spring Harbor symposia on quantitative biology  2005 
 - 419-26 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>0091-7451 
<br/><br/><label>Standard No.: </label>10.1101/sqb.2005.70.043  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--therapeutic use<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Clinical Trials as Topic<br/>Drug Resistance, Neoplasm--genetics<br/>ErbB Receptors--antagonists & inhibitors<br/>Female<br/>Gefitinib<br/>Gene Amplification<br/>Humans<br/>In Vitro Techniques<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Models, Molecular<br/>Mutation<br/>Oncogenes<br/>Quinazolines--therapeutic use